Companies similar to NKARTA INC (NKTX)
Health Care · NASDAQ
NKARTA INC (NKTX)'s closest peers include EDITAS MEDICINE INC (EDIT), CRISPR THERAPEUTICS AG (CRSP), INTELLIA THERAPEUTICS INC (NTLA), CARIBOU BIOSCIENCES INC (CRBU) and ALLOGENE THERAPEUTICS INC (ALLO). This peer set is drawn from NKTX's enriched company profile and is informational only — not financial advice.
Similar companies
-
EDITAS MEDICINE INCEDITHealth Care
A pioneering CRISPR gene editing company developing in vivo therapies for genetic diseases, with lead candidate EDIT-401 targeting hyperlipidemia through LDL…
$2.89 (as of 2026-07-21) · market cap $443M
-
CRISPR THERAPEUTICS AGCRSPHealth Care
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and…
$48.15 (as of 2026-07-21) · market cap $4.6B
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.47 (as of 2026-07-21) · market cap $1.6B
-
CARIBOU BIOSCIENCES INCCRBUHealth Care
Caribou develops off-the-shelf CRISPR-engineered CAR-T cell therapies designed to make cellular immunotherapy faster, cheaper, and accessible to more blood…
$1.65 (as of 2026-07-21) · market cap $164M
-
ALLOGENE THERAPEUTICS INCALLOHealth Care
Allogene Therapeutics is pioneering off-the-shelf, donor-derived CAR T cell therapies to provide more scalable and accessible cancer and autoimmune disease…
$1.85 (as of 2026-07-21) · market cap $633M
Not quite? Describe exactly what you want →
Peers are drawn from NKTX's enriched profile (the same similarity signal the chat uses for "companies like NKTX"). See the full profile: NKARTA INC (NKTX).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.